Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

Christopher A. Wall, Paul E Croarkin, Cosima Swintak, Brett A. Koplin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

Original languageEnglish (US)
Pages (from-to)773-788
Number of pages16
JournalChild and Adolescent Psychiatric Clinics of North America
Volume21
Issue number4
DOIs
StatePublished - Oct 2012

Fingerprint

Psychopharmacology
Pharmacogenetics
Psychiatry
Pediatrics
Hospitalization
Depression
Research
Population
Pharmacogenomic Testing

Keywords

  • Dopamine
  • Metabolism
  • Pediatric
  • Pharmacogenomics
  • Psychopharmacology
  • Receptor
  • Serotonin
  • Transporter

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health

Cite this

Psychiatric Pharmacogenomics in Pediatric Psychopharmacology. / Wall, Christopher A.; Croarkin, Paul E; Swintak, Cosima; Koplin, Brett A.

In: Child and Adolescent Psychiatric Clinics of North America, Vol. 21, No. 4, 10.2012, p. 773-788.

Research output: Contribution to journalArticle

Wall, Christopher A. ; Croarkin, Paul E ; Swintak, Cosima ; Koplin, Brett A. / Psychiatric Pharmacogenomics in Pediatric Psychopharmacology. In: Child and Adolescent Psychiatric Clinics of North America. 2012 ; Vol. 21, No. 4. pp. 773-788.
@article{22a5fd1f7a25416ba170997f4761b441,
title = "Psychiatric Pharmacogenomics in Pediatric Psychopharmacology",
abstract = "This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.",
keywords = "Dopamine, Metabolism, Pediatric, Pharmacogenomics, Psychopharmacology, Receptor, Serotonin, Transporter",
author = "Wall, {Christopher A.} and Croarkin, {Paul E} and Cosima Swintak and Koplin, {Brett A.}",
year = "2012",
month = "10",
doi = "10.1016/j.chc.2012.07.001",
language = "English (US)",
volume = "21",
pages = "773--788",
journal = "Child and Adolescent Psychiatric Clinics of North America",
issn = "1056-4993",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

AU - Wall, Christopher A.

AU - Croarkin, Paul E

AU - Swintak, Cosima

AU - Koplin, Brett A.

PY - 2012/10

Y1 - 2012/10

N2 - This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

AB - This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

KW - Dopamine

KW - Metabolism

KW - Pediatric

KW - Pharmacogenomics

KW - Psychopharmacology

KW - Receptor

KW - Serotonin

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=84867045867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867045867&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2012.07.001

DO - 10.1016/j.chc.2012.07.001

M3 - Article

VL - 21

SP - 773

EP - 788

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

SN - 1056-4993

IS - 4

ER -